Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SHD203
- Development stage
- Unknown
- Lead developer
- Shihuida Pharmaceutical Group
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Administration
- Intraperitoneal, Intralesional
01
Overview
SHD203 is a biologic drug candidate being developed by Shihuida Pharmaceutical Group. It is a recombinant human interleukin-2 (rhIL-2) intended for the treatment of malignant pleural and peritoneal effusions. Interleukin-2 is a cytokine that plays a central role in the activation and expansion of T cells and natural killer (NK) cells, enhancing the immune response against tumor cells. In the context of malignant effusions, it is typically administered via intracavitary injection to stimulate a local immune response and reduce fluid accumulation. SHD203 is currently in the IND-enabling or Phase 1 stage of development.
- Other names
- recombinant human interleukin-2rhIL-2rhIL2rhIL 2
02
Targets
IL2RB (IL-2 receptor beta chain)IL-2RA (Interleukin-2 receptor subunit alpha)
Beyond the preview
Go deeper on SHD203.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SHD203.